Antihypertensive efficacy and tolerability of Barnidipine (cas 104757-53-1) hydrochloride in patients with renal parenchymal hypertension
-
Add time:09/03/2019 Source:sciencedirect.com
ObjectiveThe goal of this study was to assess the therapeutic efficacy and tolerability of Barnidipine (cas 104757-53-1) hydrochloride in patients with renal parenchymal hypertension.
We also recommend Trading Suppliers and Manufacturers of Barnidipine (cas 104757-53-1). Pls Click Website Link as below: cas 104757-53-1 suppliers
Prev:Different photodegradation behavior of Barnidipine (cas 104757-53-1) under natural and forced irradiation
Next:Sensitive and specific liquid chromatographic–tandem mass spectrometric assay for Barnidipine (cas 104757-53-1) in human plasma) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- General paperHemodynamic effects of Barnidipine (cas 104757-53-1) hydrochloride in conscious squirrel monkeys09/07/2019
- Antihypertensive effect of Barnidipine (cas 104757-53-1) 10 mg or amlodipine 5 to 10 mg once daily in treatment-naive patients with essential hypertension: A 24-week, randomized, open-label, pilot study09/06/2019
- Effects of Barnidipine (cas 104757-53-1) hydrochloride, a calcium channel blocker, on renal microcirculation in rats: a pilot study09/05/2019
- Sensitive and specific liquid chromatographic–tandem mass spectrometric assay for Barnidipine (cas 104757-53-1) in human plasma09/04/2019
- Different photodegradation behavior of Barnidipine (cas 104757-53-1) under natural and forced irradiation09/02/2019
- Cardiovascular pharmacologyBarnidipine (cas 104757-53-1) ameliorates the vascular and renal injury in l-NAME-induced hypertensive rats09/01/2019
- Cardiovascular pharmacologyPerindopril and Barnidipine (cas 104757-53-1) alone or combined with simvastatin on hepatic steatosis and inflammatory parameters in hypertensive patients08/31/2019